PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
30-Sep-2021 Relief Reports that U.S. Collaboration Partner Announced Second Favorable Safety Report for ZYESAMI(TM) (RLF-100TM/aviptadil) in NIH Sponsored ACTIV-3b Critical Care Study in Life-Threatening COVID-19 RELIEF THERAPEUTICS Holding AG
30-Sep-2021 Relief's Subsidiary, APR Applied Pharma Research, Reports Data Published in Journal of Wound Care, Indicating Nexodyn(R) AOS Highly Effective Treatment to Support Healing of Hard-to-Heal Leg Ulcers RELIEF THERAPEUTICS Holding AG
29-Sep-2021 First Surgery with Medacta's Minimally Invasive M.U.S.T. MC Platform Medacta Group SA
29-Sep-2021 Reference to Potential SRA737 Clinical Development Timeline in Sierra Oncology Investor Presentation at 2021 Cantor Virtual Global Healthcare Conference Sareum Holdings plc
29-Sep-2021 Aptamer Group and BizCom announce collaboration for Optimer distribution and marketing services in Japan Aptamer Group
29-Sep-2021 Dolomite Bio launches new RNAdia kit, breaking down cost barriers for single cell research Dolomite Bio
29-Sep-2021 Industry peers recognise and reward Pharmadoctor’s achievements with two more golds at the prestigious PM Society Digital Awards. Pharmadoctor
29-Sep-2021 Eagle Genomics and the Earlham Institute to deliver new microbiome multi-omics datasets and tools Eagle Genomics
29-Sep-2021 Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC) Bone Therapeutics
29-Sep-2021 ViiV Healthcare presents three-year switch data for Dovato (dolutegravir/lamivudine) confirming long-term, non-inferior efficacy with no virologic failure versus continuation of TAF-based regimens of at least three drugs ViiV Healthcare
29-Sep-2021 Third ADC with Synaffix’s Technology Enters Clinical Development Synaffix B.V.
29-Sep-2021 New BIMZELX®▼ (bimekizumab) two-year data in moderate to severe plaque psoriasis presented at the 30th European Academy of Dermatology and Venereology (EADV) Congress UCB
29-Sep-2021 HUTCHMED Highlights Oral Presentations at 2021 Chinese Society of Clinical Oncology Annual Meeting HUTCHMED
29-Sep-2021 Novartis awarded Promising Innovative Medicine designation for targeted radioligand theragnostics in prostate cancer Novartis
29-Sep-2021 Movember and Sermo Partner to Increase Physician Conversation Around Prostate Cancer Sermo
29-Sep-2021 Pharma.Aero Shares Lean Logistics for Vaccines Distribution showcasing Uruguay's Logistics Model Pharma.Aero
29-Sep-2021 Immutep to Present at Healthcare Investor Conferences Immutep
29-Sep-2021 Tiziana Life Sciences plc - Interim Results for the Six Months Ended 30 June 2021 Tiziana Life Sciences
29-Sep-2021 Worg Pharmaceuticals to Acquire Apitope International Worg Pharmaceuticals
29-Sep-2021 Johnson & Johnson Celebrates COVID-19 Vaccine Science Superheroes Johnson & Johnson